Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "sandoz inc"

NOVARTIS : Sandoz Canada Expands Its Cancer Medication Portfolio With the Launch of (PR)Oxaliplatin Injection

BOUCHERVILLE, QC -- (Marketwired) -- 02/04/16 -- Sandoz Canada Inc., a Novartis company, continues to expand its cancer medication portfolio with the recent launch of Pr Oxaliplatin Injection, which is given along with other medicines to treat ...
 4 Traders1 week ago Sandoz Canada Expands Its Cancer Medication Portfolio With the Launch of (PR)Oxaliplatin Injection  Benzinga.com1 week ago
[x]  
Mr Top Step

Novartis Filing for Neulasta Biosimilar Accepted in the EU

Novartis AG NVS announced that the European Medicines Agency (EMA) has accepted its generic arm, Sandoz's Marketing Authorization Application (MAA) for a proposed biosimilar of Amgen's AMGN Neulasta (pegfilgrastim). The MAA includes results from ...
 Yahoo! Finance1 day ago
[x]  
Zacks.com

Pfizer's Biosimilar of Remicade Recommended for Approval

Pfizer Inc. PFE announced that the FDA's Arthritis Advisory Committee has recommended an approval (by a vote of 21 to 3) of its experimental biosimilar of Johnson & Johnson's JNJ Remicade (infliximab). The committee recommended the approval of the ...
 Yahoo! Finance3 days ago Celltrion's Proposed REMICADE┬« Biosimilar Recommended for Approval  JD Supra3 days ago
[x]  
Nasdaq

Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook

Biotech major, Amgen Inc. AMGN, reported fourth quarter 2015 earnings of $2.61 per share, well above the Zacks Consensus Estimate of $2.27 and the year-ago earnings of $2.16. Amgen Inc. (AMGN) Street EPS & Surprise Percent - Last 5 Quarters | ...
 Yahoo! Finance2 weeks ago
Bidness Etc

Amgen Loses Enbrel to Biogen in Europe; Can It Cope?

The worst part of the patent cliff for Amgen, Inc. ( NASDAQ:AMGN ) is just beginning. On Monday, the European Commission (EC) granted marketing approval to the first biosimilar for Enbrel, the biotech giant's blockbuster medicine. The drug, ...
 Bidness Etc3 weeks ago
Nasdaq

Biogen's (BIIB) Biosimilar of Amgen's Enbrel Gets EU Nod

Biogen Inc. BIIB announced that its joint venture with Samsung Biologics, Samsung Bioepis, has received marketing authorization for Benepali in the EU. Benepali is a biosimilar version of Amgen Inc.'s AMGN Enbrel (etanercept). Benepali is approved ...
 Yahoo! Finance3 weeks ago Samsung Bioepis And Biogen: A Profitable Case For SB2 And Enbrel  Seeking Alpha1 week ago
[x]  
TeleTrader.com

Sandoz Acquires Pfizer's Biosimilar Infliximab In EEA

BASEL (dpa-AFX) - Sandoz, a Novartis (NVS) company, announced that it has acquired from Pfizer the rights for the development and commercialization of PF-06438179 (biosimilar infliximab) in the 28 countries that form the European Economic Area. ...
 Pharmacy Choice2 days ago Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer's biosimilar infliximab in EEA  SPi World News2 days ago EMA Accepts Sandoz Biosimilar Regulatory Submission for Pegfilgrastim  American Pharmaceutical Review3 days ago Sandoz advances its biosimilars program with EMA acceptance of regulatory submission for biosimilar pegfilgrastim  SPi World News3 days ago
[x]  

Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory Affairs

NEW HAVEN, Conn., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the addition of two members to the senior management team. Martha Manning, Esq., joins Achillion as Executive Vice President, General ...
 4 Traders1 week ago Achillion (ACHN) Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs  FierceBiotech1 week ago
[x]  
TeleTrader.com

Teva And Eagle Pharmaceuticals Announce Commercial Availability Of BENDEKA (bendamustine Hydrochloride) Injection

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced today the commercial availability of BENDEKA, (bendamustine hydrochloride) injection, a liquid, low-volume (50 mL) and short-time ...
 TheStreet.com2 weeks ago Teva and Checkpoint Therapeutics announce license agreement for Oral PARP Inhibitor  Pharmaceutical Tech.com1 month ago Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies  TMC Net1 week ago Teva And AbCellera Biologics Enter Into Agreement To Discover Rare Monoclonal Antibodies  BioSpace1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less